Seroprevalence of hepatitis C virus (HCV) infection among blood donors: a hospital-based study (Q45735948)

15 December 2017

Seroprevalence of hepatitis C virus (HCV) infection among blood donors: a hospital-based study (English)

1 reference

15 December 2017

0 references

1 reference

Tamim H

1

1 reference

15 December 2017

Irani-Hakime N

2

1 reference

15 December 2017

Aoun JP

3

1 reference

15 December 2017

Khoury S

4

1 reference

15 December 2017

Samaha H

5

1 reference

15 December 2017

Almawi WY

6

1 reference

15 December 2017

1 February 2001

1 reference

Transfusion and Apheresis Science

15 December 2017

1 reference

15 December 2017

24

1 reference

15 December 2017

1

1 reference

15 December 2017

29-35

1 reference

Natural history of hepatitis C.

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Discovery of non-A, non-B hepatitis and identification of its etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Reducing the risk of infection from plasma products: specific preventative strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Spread of hepatitis C virus among sexual partners of HCVAb positive intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Sexual transmission of hepatitis C virus to a repeat blood donor

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

A French consensus conference on hepatitis C: screening and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Infectivity of blood seropositive for hepatitis C virus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

High prevalence of HCV-antibody among Egyptian blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Prevalence of antibody to hepatitis C virus in a blood donor population

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Epidemiology of HCV infection in the general population and in blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Prevalence of antibodies against hepatitis C virus in the adult German population.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Prevalence of hepatitis C virus genotypes in southern Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Antibody to hepatitis C virus in German blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Antibodies to hepatitis C virus in Italian blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Antibodies to hepatitis C virus in French blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Large-scale HCV RNA screening in first-time blood donors: the first step towards genomic screening of blood donations. HCV RNA Screening Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

Prevalence of anti-HCV antibody in blood donors in the Tokyo area

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900124-7

7 January 2021

10.1016/S0955-3886(00)00124-7

Identifiers

DOI

1 reference

15 December 2017

1 reference